The global irritable bowel syndrome treatment market was valued at USD 2.63 billion in 2024, driven by increasing awareness and demand for targeted therapies. With a projected CAGR of 10.10% from 2025 to 2034, the market is expected to reach nearly USD 6.88 billion by 2034, highlighting growing emphasis on improving gastrointestinal health and quality of life. https://www.expertmarketresearch.com/reports/irritable-bowel-syndrome-treatment-market